Piper Jaffray & Co.

UPDATE: Piper Jaffray Lowers PT on The Fresh Market Following FQ2 EPS Report

UPDATE: Piper Jaffray Lowers PT on Integra Following Anasco Recall

UPDATE: Piper Jaffray Upgrades Electronic Arts to Overweight on Compelling Margin Opportunities

UPDATE: Piper Jaffray Lowers PT on Integra Following Anasco Recall

UPDATE: Piper Jaffray Upgrades Electronic Arts to Overweight on Compelling Margin Opportunities

UPDATE: Piper Jaffray Lowers PT on Guess? on Below-Expectations Guidance

UPDATE: Piper Jaffray Lifts Electronic Arts PT on Revised Expectations for New Console Cycle

UPDATE: Piper Jaffray Lowers PT on Guess? on Below-Expectations Guidance

UPDATE: Piper Jaffray Lifts Electronic Arts PT on Revised Expectations for New Console Cycle

UPDATE: Piper Jaffray Raises Amgen PT to $107, Says Short Term Strength Expected From Omontys Failure

UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on ITT Educational Services

Piper Jaffray & Co. Recent News

UPDATE: Piper Jaffray Reiterates Overweight Rating, Raises PT on Cree

UPDATE: Piper Jaffray Reiterates Neutral Rating, Raises PT on Polycom

UPDATE: Piper Jaffray Reiterates Overweight Rating, Lowers PT on McGraw-Hill Companies

UPDATE: Piper Jaffray Reiterates Overweight Rating, Raises PT on Moody's Corporation

UPDATE: Piper Jaffray Reiterates Overweight Rating, Lowers PT on Moneygram International

Piper Jaffray Reiterates Neutral Rating, $13 PT on Best Buy

UPDATE: Piper Jaffray Reiterates Neutral Rating, Raises PT on Alliance Data Systems Corporation

UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on Tilly's

UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on Pacific Sunwear of California

UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on Deckers Outdoor Corp.

UPDATE: Piper Jaffray Downgrades Aeropostale to Neutral, Lowers PT

UPDATE: Piper Jaffray Reiterates Overweight Rating, Raises PT on HSN

UPDATE: Piper Jaffray Reiterates Neutral Rating, Raises PT on Apollo Group

Piper Jaffray Reiterates Overweight Rating, $100 PT on athenahealth

UPDATE: Piper Jaffray Reiterates Neutral Rating, Raises PT on Sequenom

UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on Synageva BioPharma Corp.

UPDATE: Piper Jaffray Downgrades Endo Health Solutions to Neutral, Lowers PT

UPDATE: Piper Jaffray Initiates Coverage on Cytokinetics with Overweight Rating, $4 PT

UPDATE: Piper Jaffray Downgrades Cepheid to Neutral, Lowers PT

UPDATE: Piper Jaffray Initiates Coverage on BioDelivery Sciences International with Neutral Rating, $5 PT

UPDATE: Piper Jaffray Initiates Coverage on Avanir Pharmaceuticals with Overweight Rating, $6 PT

UPDATE: Piper Jaffray Initiates Coverage on Alexza Pharmaceuticals to Neutral Rating, $5 PT

Piper Jaffray Reiterates Overweight Rating, $103 PT on Watson Pharmaceuticals